Benralizumab reduces sputum ANCA in patients with eosinophilic granulomatosis with polyangiitis

Podobne zapisy

• Benralizumab reduces sputum ANCA in patients with eosinophilic granulomatosis with polyangiitis
  od: Manali Mukherjee, i wsp.
  Wydane: (2026-03-01)
• Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
  od: Charlene Desaintjean, i wsp.
  Wydane: (2024-03-01)
• Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
  od: Andrea Portacci, i wsp.
  Wydane: (2023-10-01)
• Patients’ perspectives of eosinophilic granulomatosis with polyangiitis within the context of a clinical trial
  od: Peter A. Merkel, i wsp.
  Wydane: (2025-10-01)
• Case Report: Benralizumab-induced remission in adolescent-onset ANCA-positive eosinophilic granulomatosis with polyangiitis
  od: Milica Terzic, i wsp.
  Wydane: (2026-07-01)